Company Filing History:
Years Active: 1980-1988
Title: The Innovative Contributions of Fritz H Kemper
Introduction
Fritz H Kemper, based in Muenster, Germany, is a renowned inventor recognized for his significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Kemper has demonstrated an exceptional ability to enhance the bioavailability and effectiveness of various pharmacologically active agents through innovative formulations.
Latest Patents
Kemper's latest patents showcase his focus on creating readily absorbable pharmaceutical compositions. His first notable patent involves a composition designed for poorly absorbable pharmacological agents, which incorporates a vehicle containing an absorption-enhancing amount of medium chain fatty acids. This formulation is particularly useful for cardiac glycosides, steroids, antibiotics, sympathomimetics, tranquilizers, and local anesthetics.
In addition, he has developed a carrier composition for topical pharmaceutical formulations aimed at improving cutaneous absorption of active agents. This composition, comprising partial glycerides of medium chain fatty acids, enhances the permeation of active ingredients through the skin, making it suitable for both local and systemic effects.
Career Highlights
Fritz H Kemper works for Kali-Chemie Pharma GmbH, a company that focuses on pharmaceutical innovations. His work is integral to the development of new pharmaceutical formulations that can greatly benefit medical treatments and therapies, thus improving patient outcomes.
Collaborations
Throughout his career, Kemper has collaborated with notable professionals in the industry, including Theodor Eckert and Martin Wischniewski. These partnerships have further fueled innovative research and advancements in enhancing drug absorption and efficacy.
Conclusion
Fritz H Kemper's dedication to innovation in the pharmaceutical field is evident through his patents and collaborations. His work has the potential to transform the ways in which pharmacologically active agents are delivered to patients, marking him as a significant figure in the realm of pharmaceutical inventions.